These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 14072529)

  • 1. TOTAL BODY PERFUSION IN CARDIAC OPERATIONS; USE OF PERFUSATE OF BALANCED ELECTROLYTES AND LOW MOLECULAR WEIGHT DEXTRAN.
    ROE BB; SWENSON EE; HEPPS SA; BRUNS DL
    Arch Surg; 1964 Jan; 88():128-34. PubMed ID: 14072529
    [No Abstract]   [Full Text] [Related]  

  • 2. THE USE OF LOW MOLECULAR WEIGHT DEXTRAN (RHEOMACRODEX) AS AN ANTICOAGULANT IN LEFT ATRIAL TO FEMORAL ARTERY BYPASS.
    DUBIEL-TOMASZEWSKI W; STERN WR; HALL DP
    J Thorac Cardiovasc Surg; 1965 Aug; 50():221-8. PubMed ID: 14321521
    [No Abstract]   [Full Text] [Related]  

  • 3. [SURGICAL TREATMENT OF HEART DEFECTS, USING A HEART-LUNG MACHINE FOR THE PERFUSION WITH THE PATIENT'S OWN BLOOD AND RHEOMACRODEX].
    HEGEMANN G; GALL F; LEUTSCHAFT R; ULMER H
    Thoraxchir Vask Chir (1962); 1964 Jul; 12():48-56. PubMed ID: 14254690
    [No Abstract]   [Full Text] [Related]  

  • 4. Blood-loss in open-heart surgery with low-molecular-weight dextran.
    BRECKENRIDGE IM; WALKER WF
    Lancet; 1963 Jun; 1(7292):1190-1. PubMed ID: 14015153
    [No Abstract]   [Full Text] [Related]  

  • 5. INTENTIONAL HEMODILUTION. USE OF A ROTATING DISC OXYGENATOR PRIMED WITH ACID CITRATE DEXTROSE BLOOD AND LOW MOLECULAR WEIGHT DEXTRAN: A PRELIMINARY REPORT.
    ABLAZA SG; RABER GT; BLANCO G; MORSE DP; ADAM A; NICHOLS HT
    Arch Surg; 1963 Oct; 87():548-53. PubMed ID: 14056229
    [No Abstract]   [Full Text] [Related]  

  • 6. SOME ASPECTS OF HAEMOSTASIS AFTER OPEN-HEART SURGERY.
    DEGABRIELE G
    J Clin Pathol; 1963 Nov; 16(6):569-72. PubMed ID: 14076376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CLINICAL AND PHYSIOLOGICAL RESULTS OF PERFUSION WITH DILUTED BLOOD.
    PATON BC; ROSENKRANTZ JG; BLOUNT SG
    Circulation; 1964 Apr; 29():SUPPL:63-6. PubMed ID: 14150971
    [No Abstract]   [Full Text] [Related]  

  • 8. POST-PERFUSION LUNG SYNDROME: EFFECT OF HOMOLOGOUS BLOOD.
    NAHAS RA; MELROSE DG; SYKES MK; ROBINSON B
    Lancet; 1965 Aug; 2(7406):254-6. PubMed ID: 14330057
    [No Abstract]   [Full Text] [Related]  

  • 9. A HEMODILUTION TECHNIQUE FOR OPEN-HEART SURGERY: A PRELIMINARY CLINICAL REPORT.
    KELKAR K; PALOSCHI GB; WEST RO; HORNE GR; LYNN RB
    Can Med Assoc J; 1964 Dec; 91(23):1197-9. PubMed ID: 14226092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Independent measurement of temperature and viscosity of perfusion volume].
    BRETSCHNEIDER HJ
    Langenbecks Arch Klin Chir Ver Dtsch Z Chir; 1961; 298():774-7. PubMed ID: 13872934
    [No Abstract]   [Full Text] [Related]  

  • 11. HEMODILUTION IN EXTRACORPORAL CIRCULATION: COMPARATIVE STUDY OF LOW MOLECULAR WEIGHT DEXTRAN AND 5 PERCENT DEXTROSE.
    MAINARDI LC; BHANGANADA K; MACK JD; LILLEHEI CW
    Surgery; 1964 Aug; 56():349-54. PubMed ID: 14213830
    [No Abstract]   [Full Text] [Related]  

  • 12. THE EFFECT OF DEXTRAN AND MANNITOL ON RENAL FUNCTION DURING OPEN-HEART SURGERY.
    KAHN DR; CERNY JC; LEE RW; SLOAN H
    Surgery; 1965 May; 57():676-9. PubMed ID: 14295778
    [No Abstract]   [Full Text] [Related]  

  • 13. [CLINICAL USE OF A LOW MOLECULAR WEIGHT DEXTRAN].
    CORMIER JM; SULZER J
    Presse Med (1893); 1964 Dec; 72():3429-32. PubMed ID: 14231417
    [No Abstract]   [Full Text] [Related]  

  • 14. THE FEASIBILITY OF HYPOTHERMIC PERFUSION UNDER HYPERBARIC CONDITIONS IN THE SURGICAL MANAGEMENT OF INFANTS WITH CYANOTIC CONGENITAL HEART DISEASE.
    BERNHARD WF; TANK ES; FRITTELLI G; GROSS RE
    J Thorac Cardiovasc Surg; 1963 Nov; 46():651-64. PubMed ID: 14087738
    [No Abstract]   [Full Text] [Related]  

  • 15. [ON THE FUNCTION OF ARTIFICIAL OXYGENATORS WITH LOW BLOOD TEMPERATURES].
    OVERBECK W
    Langenbecks Arch Klin Chir Ver Dtsch Z Chir; 1964 Jan; 305():126-38. PubMed ID: 14126338
    [No Abstract]   [Full Text] [Related]  

  • 16. HIGH FLOW TOTAL BODY PERFUSION UTILIZING DILUTED PERFUSATE IN A LARGE PRIME SYSTEM.
    LITWAK RS; GADBOYS HL; KAHN M; WISOFF BG
    J Thorac Cardiovasc Surg; 1965 Jan; 49():74-90. PubMed ID: 14261876
    [No Abstract]   [Full Text] [Related]  

  • 17. Influence of blood viscosity on blood flow and the effect of low molecular weight dextran.
    Dormandy JA
    Br Med J; 1971 Dec; 4(5789):716-9. PubMed ID: 5129616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HEMODILUTION, TONICITY, AND BLOOD VISCOSITY.
    RAND PW; LACOMBE E
    J Clin Invest; 1964 Nov; 43(11):2214-26. PubMed ID: 14223933
    [No Abstract]   [Full Text] [Related]  

  • 19. [THE USE OF LOW MOLECULAR WEIGHT DEXTRAN AS A PRIMER IN EXTRACORPOREAL CIRCULATION IN EXPERIMENTS ON DEEP HYPOTHERMIA].
    DEORUETA A; CAFFARENA JM; VALLEJO JL; REGODON J
    Rev Clin Esp; 1963 Sep; 90():369-74. PubMed ID: 14091642
    [No Abstract]   [Full Text] [Related]  

  • 20. CONTROL OF ACIDOSIS AND THE USE OF TITRATED ACD BLOOD IN OPEN-HEART SURGERY.
    NAHAS GG; MALM JR; MANGER WM; VEROSKY M; SULLIVAN SF
    Ann Surg; 1964 Dec; 160(6):1049-56. PubMed ID: 14246141
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.